
News|Articles|March 17, 2026
Challenging Cases®: Firsthand insight into oncology decision‑making
Through interactive, quantitative live and virtual double-blinded case-based sessions followed by a national key opinion leader data-focused discussion, Challenging Cases offers a window into how oncologists select treatment options, balance clinical considerations, and respond to complex patient scenarios, providing insight into the factors shaping real-world treatment decisions.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
5